Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.
about
Thrombin activation and liver inflammation in advanced hepatitis C virus infectionBenign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus InfectionHuman platelets and their capacity of binding viruses: meaning and challenges?A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis BA brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology.A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosisPlatelet count increase following phlebotomy in iron overloaded patients with liver cirrhosis.Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia.The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura.Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.Pathobiology of secondary immune thrombocytopenia.Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.Pathobiology and treatment of hepatitis virus-related thrombocytopenia.Factors predicting persistent thrombocytopenia after living donor liver transplantation in pediatric patients.Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet countsCauses of thrombocytopenia in chronic hepatitis C viral infection.Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesPathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.Exposure-toxicity relationship of sorafenib in Japanese patients with renal cell carcinoma and hepatocellular carcinoma.Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Kasabach-Merritt phenomenon in an adult man with a tufted angioma and cirrhosis responding to radiation, bevacizumab, and prednisone.Determinants of platelet count are different in patients with compensated and decompensated cirrhosis.Transient Elastography for Spleen Stiffness Measurement in Patients With Cirrhosis: Role in Degree of Thrombocytopenia.Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia.Thrombocytopenia in chronic liver disease.Thrombocytopenia in Patients with Chronic Hepatitis C Virus InfectionNon-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patientsNon invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis.Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosisA practical approach to managing patients with HCV infection.Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C.Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALTManagement of chronic hepatitis C virus infection: a new era of disease control.AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis.
P2860
Q26749460-5301D271-DE80-4A99-B646-DECF8E07FB50Q26775733-2788334F-C7D4-47ED-B592-A7EE52DFA716Q26997803-E6D8A5A1-EF39-420A-B3ED-1474F92896FFQ28741501-9EF0F3B8-EB3F-42B8-A4D4-103A1FE4A563Q30476922-5721534F-91BE-41E3-B760-BD8558CF1218Q30665307-E391E04A-7266-4444-9535-5B32D1AA61CFQ31157282-60846F68-EDAE-40F0-82C3-EE9BCCE23199Q33349456-A43C972E-3FAE-4C0C-B948-CCEE7D7DE6DBQ33365357-F52C52AE-13FB-4D2C-8ADC-7AFCE385036FQ33366601-FF934795-F624-4560-8DBE-700B16BD93F4Q33366747-5C4BE143-54C9-4FE3-9C63-682892686E91Q33368703-C8AD8D2A-9AD1-420A-AE4B-0C863371930AQ33382854-D70A7852-E254-4D15-80C3-29EDE9539ED5Q33383468-64782238-7036-42A8-AE9C-AF87976D768AQ33386133-86D3548F-4D67-48F3-8803-FDE61DC1FB5FQ33387808-84A96182-AE26-4571-9209-F83D545C2D93Q33394547-1649EF46-2081-48C5-AC75-C0E76A088174Q33396362-2357B12D-FA5E-4751-AC6B-EF8C07CBE981Q33399240-5E6F67BA-CA46-40BA-8A51-901B58FC5CD0Q33399654-FC354CBB-9C48-4D41-9A6C-A3A93B6309A9Q33401841-5B42C4F7-F432-4A87-882D-98C7820E8FBFQ33403517-CFB824A6-C69C-4153-8747-95BD82D5B944Q33405017-9571E5BA-983E-4E62-8476-ED3A443336A8Q33411001-A35304CB-4812-447E-AF18-C64C4F564494Q33411544-CA8F50AB-55A6-4B6A-993F-698686506821Q33414386-550FD4A5-AD44-4670-8B7A-7A0A5B24C1C4Q33414391-3DD89EEF-B567-464C-B983-8508FA370EE8Q33424074-3D674D1C-9F98-4CEF-AA29-3CBD80966BA4Q33433589-4270E496-6D31-48B7-89B8-7ACE3F302C4FQ33433774-FB757DC1-C540-410F-AA62-2C8C4078AB55Q33436905-9E02D3BB-AF17-4245-951F-B1B4425BB167Q33440130-53A6ED2E-2BFE-4323-90C1-CC87E701B80CQ33599576-30EA57D2-4D7F-4FBE-B8A4-EE6A808A4936Q33866722-C681A257-9D3D-42D1-8668-DA4D96438CD2Q34418673-8C6CC861-7C40-4E88-8A73-6DE7240C82F3Q34485082-84C14285-4EAA-4030-9DC7-2C299B0CED49Q35011152-C25E6A6F-16E4-4B4F-91C8-4B18A3FFA384Q35049139-3720AF1E-E099-41EB-834F-A1CF356C3ACFQ35823410-ED4A945C-3EED-46DA-AB64-CFD38D79A64BQ36664042-6AEDFB90-331A-4D35-A5CE-D0593789D274
P2860
Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@ast
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@en
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@nl
type
label
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@ast
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@en
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@nl
prefLabel
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@ast
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@en
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@nl
P2093
P2860
P921
P1476
Hepatic fibrosis plays a centr ...... with chronic viral hepatitis.
@en
P2093
Adinolfi LE
Andreana A
Durante Mangoni E
Giordano MG
Ruggiero G
Tripodi MF
P2860
P304
P356
10.1046/J.1365-2141.2001.02824.X
P407
P577
2001-06-01T00:00:00Z